• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肾上腺偶发瘤患者地塞米松抑制试验后皮质醇浓度升高与下丘脑-垂体-肾上腺轴的激素改变相关。

Elevated post-dexamethasone suppression cortisol concentrations correlate with hormonal alterations of the hypothalamo-pituitary adrenal axis in patients with adrenal incidentalomas.

作者信息

Tsagarakis S, Roboti C, Kokkoris P, Vasiliou V, Alevizaki C, Thalassinos N

机构信息

Department of Endocrinology, Diabetes and Metabolism, Evangelismos' Hospital, Athens, Greece.

出版信息

Clin Endocrinol (Oxf). 1998 Aug;49(2):165-71. doi: 10.1046/j.1365-2265.1998.00509.x.

DOI:10.1046/j.1365-2265.1998.00509.x
PMID:9828902
Abstract

OBJECTIVE

It has recently been suggested that autonomous cortisol production may lead to subclinical glucocorticoid excess in a substantial number of patients with incidentally discovered adrenocortical adenomas. Following a standard low-dose dexamethasone suppression test (LDDST) cortisol concentrations are frequently incompletely suppressed in patients with adrenal incidentalomas, due to an ACTH-independent secretion of cortisol by the adrenal mass. Thus, post LDDST cortisol concentrations may provide a measure of the degree of autonomous glucocorticoid secretion, but hormonal alterations in relation to post-LDDST cortisol concentrations have not been thoroughly investigated.

PATIENTS AND MEASUREMENTS

61 patients with radiological features highly suggestive of adrenal adenomas were studied. These included 43 women, 18 men; mean age 59 +/- 1.4, range: 25-76 years; BMI 30.9 +/- 0.8 kg/m2 and waist:hip ratio 0.90 +/- 0.016. All subjects underwent a standard LDDST, as follows: after a 48-hr stabilisation period, 24-hr urine collections for basal urinary free cortisol (UFC) were performed. Basal serum cortisol and plasma ACTH were measured at 8 AM and at midnight the following day, and subjects started dexamethasone 0.5 mg 6 hourly for 2 days. Post-dexamethasone cortisol and ACTH levels were measured at 8 AM, 6-hrs after the last dose of dexamethasone. Blood samples for dehydroepiandrosterone sulphate (DHEAS) and serum lipids were obtained on the morning preceding dexamethasone administration.

RESULTS

Post-LDDST cortisol concentrations correlated positively with the size of the adenoma (r = +0.527, P < 0.001). There was a negative rank correlation of post-LDDST cortisol concentrations and basal ACTH levels at 0900 h (rs = -0.426, P < 0.001) and DHEAS (rs = -0.380, P = 0.006). Moreover, there was a good rank correlation between DHEAS and basal ACTH levels (rs = +0.456, P < 0.001). A positive rank correlation was observed between post-LDDST cortisol concentrations and midnight cortisol concentrations (rs = +0.317, P = 0.020). As recent studies have suggested that post-LDDST cortisol levels higher than 70 nmol/l may indicate significant hypercortisolism comparisons were also performed between patients divided according to post-LDDST cortisol values into 3 groups: Group A, > 70 nmol/l (19 pts); Group B, 30-70 nmol/l (27 pts); Group C, < 30 nmol/l (15 pts). Although there was no difference in basal cortisol and UFC values between these groups, ACTH and DHEAS levels were significantly lower, and midnight cortisol significantly higher in group A compared to group C patients (P = 0.030, P = 0.017 and P = 0.001 respectively). Cholesterol and triglyceride levels were slightly albeit significantly higher in group A compared to group C patients (P < 0.05).

CONCLUSIONS

It is concluded that higher post-low dose dexamethasone cortisol concentrations are associated with lower ACTH and dehydroepiandrosterone sulphate, higher midnight cortisol concentrations and larger adenomas. These findings are consistent with the hypothesis that post-low dose dexamethasone cortisol concentrations represent a useful index in assessing subtle glucocorticoid autonomy in patients with adrenal adenomas.

摘要

目的

最近有人提出,在大量偶然发现肾上腺皮质腺瘤的患者中,自主性皮质醇分泌可能导致亚临床糖皮质激素过多。在标准低剂量地塞米松抑制试验(LDDST)后,肾上腺意外瘤患者的皮质醇浓度常常不能被完全抑制,这是由于肾上腺肿物可独立于促肾上腺皮质激素(ACTH)分泌皮质醇。因此,LDDST后的皮质醇浓度可能提供了一种衡量自主性糖皮质激素分泌程度的指标,但与LDDST后皮质醇浓度相关的激素变化尚未得到充分研究。

患者与测量

对61例具有高度提示肾上腺腺瘤影像学特征的患者进行了研究。其中包括43名女性,18名男性;平均年龄59±1.4岁,范围:25 - 76岁;体重指数(BMI)30.9±0.8kg/m²,腰臀比0.90±0.016。所有受试者均接受了标准的LDDST,具体如下:在48小时稳定期后,进行24小时尿液收集以检测基础尿游离皮质醇(UFC)。在上午8点和次日午夜测量基础血清皮质醇和血浆ACTH,受试者开始每6小时服用0.5mg地塞米松,共服用2天。在最后一剂地塞米松服用6小时后的上午8点测量地塞米松后的皮质醇和ACTH水平。在服用地塞米松前一天上午采集血样检测硫酸脱氢表雄酮(DHEAS)和血脂。

结果

LDDST后的皮质醇浓度与腺瘤大小呈正相关(r = +0.527,P < 0.001)。LDDST后的皮质醇浓度与上午9点的基础ACTH水平(rs = -0.426,P < 0.001)和DHEAS(rs = -0.380,P = 0.006)呈负等级相关。此外,DHEAS与基础ACTH水平之间存在良好的等级相关(rs = +0.456,P < 0.001)。LDDST后的皮质醇浓度与午夜皮质醇浓度呈正等级相关(rs = +0.317,P = 0.020)。由于最近的研究表明,LDDST后皮质醇水平高于70nmol/l可能表明存在明显的皮质醇增多症,因此还根据LDDST后的皮质醇值将患者分为3组进行比较:A组,> 70nmol/l(19例);B组,30 - 70nmol/l(27例);C组,< 30nmol/l(15例)。尽管这些组之间的基础皮质醇和UFC值没有差异,但与C组患者相比,A组患者的ACTH和DHEAS水平显著降低,午夜皮质醇显著升高(分别为P = 0.030,P = 0.017和P = 0.001)。与C组患者相比,A组患者的胆固醇和甘油三酯水平略高但有显著差异(P < 0.05)。

结论

得出结论,低剂量地塞米松后较高的皮质醇浓度与较低的ACTH和硫酸脱氢表雄酮、较高的午夜皮质醇浓度以及较大的腺瘤相关。这些发现与以下假设一致,即低剂量地塞米松后的皮质醇浓度是评估肾上腺腺瘤患者细微糖皮质激素自主性的一个有用指标。

相似文献

1
Elevated post-dexamethasone suppression cortisol concentrations correlate with hormonal alterations of the hypothalamo-pituitary adrenal axis in patients with adrenal incidentalomas.肾上腺偶发瘤患者地塞米松抑制试验后皮质醇浓度升高与下丘脑-垂体-肾上腺轴的激素改变相关。
Clin Endocrinol (Oxf). 1998 Aug;49(2):165-71. doi: 10.1046/j.1365-2265.1998.00509.x.
2
The low-dose dexamethasone suppression test in patients with adrenal incidentalomas: comparisons with clinically euadrenal subjects and patients with Cushing's syndrome.肾上腺偶发瘤患者的小剂量地塞米松抑制试验:与临床肾上腺功能正常者及库欣综合征患者的比较
Clin Endocrinol (Oxf). 1998 May;48(5):627-33. doi: 10.1046/j.1365-2265.1998.00464.x.
3
Alterations in hypothalamic-pituitary-adrenal function immediately after resection of adrenal adenomas in patients with Cushing's syndrome and others with incidentalomas and subclinical hypercortisolism.库欣综合征患者和偶发瘤及亚临床皮质醇增多症患者肾上腺腺瘤切除术后即刻下丘脑-垂体-肾上腺功能的改变。
Endocrine. 2019 Jan;63(1):140-148. doi: 10.1007/s12020-018-1769-z. Epub 2018 Sep 27.
4
Study of glucose tolerance in consecutive patients harbouring incidental adrenal tumours. Study Group of Incidental Adrenal Adenoma.对连续患有偶发性肾上腺肿瘤患者的葡萄糖耐量研究。偶发性肾上腺腺瘤研究组。
Clin Endocrinol (Oxf). 1998 Jul;49(1):53-61. doi: 10.1046/j.1365-2265.1998.00437.x.
5
131I-6 beta-iodomethylnorcholesterol scintigraphy: an assessment of its role in the investigation of adrenocortical incidentalomas.131I-6β-碘甲基去甲胆固醇闪烁扫描术:评估其在肾上腺皮质意外瘤检查中的作用
Clin Endocrinol (Oxf). 1996 May;44(5):587-96. doi: 10.1046/j.1365-2265.1996.720541.x.
6
Subclinical Cushing's syndrome in adrenal incidentaloma.肾上腺偶发瘤中的亚临床库欣综合征
Clin Endocrinol (Oxf). 1998 Jan;48(1):89-97. doi: 10.1046/j.1365-2265.1998.00357.x.
7
Low DHEAS: A Sensitive and Specific Test for the Detection of Subclinical Hypercortisolism in Adrenal Incidentalomas.低硫酸脱氢表雄酮:检测肾上腺意外瘤中亚临床皮质醇增多症的一项敏感且特异的检查
J Clin Endocrinol Metab. 2017 Mar 1;102(3):786-792. doi: 10.1210/jc.2016-2718.
8
Adrenal incidentaloma: an overview of hormonal data from the National Italian Study Group.肾上腺偶发瘤:来自意大利国家研究小组的激素数据概述
Horm Res. 1997;47(4-6):284-9. doi: 10.1159/000185478.
9
Subclinical Cushing's syndrome in patients with adrenal incidentaloma: clinical and biochemical features.肾上腺偶发瘤患者的亚临床库欣综合征:临床和生化特征
J Clin Endocrinol Metab. 2000 Apr;85(4):1440-8. doi: 10.1210/jcem.85.4.6515.
10
Reduced serum levels of dehydroepiandrosterone sulphate in adrenal incidentalomas: a marker of adrenocortical tumour.肾上腺偶发瘤患者血清硫酸脱氢表雄酮水平降低:肾上腺皮质肿瘤的一个标志物
Clin Endocrinol (Oxf). 1995 Feb;42(2):129-34. doi: 10.1111/j.1365-2265.1995.tb01852.x.

引用本文的文献

1
Thyroid function spectrum in Cushing's syndrome.库欣综合征的甲状腺功能谱。
BMC Endocr Disord. 2024 Jun 6;24(1):80. doi: 10.1186/s12902-024-01614-4.
2
LIFESTYLE AND ANTHROPOMETRIC PARAMETERS IN PATIENTS WITH NONFUNCTIONAL ADRENAL INCIDENTALOMAS.非功能性肾上腺偶发瘤患者的生活方式和人体测量参数
Acta Endocrinol (Buchar). 2023 Jan-Mar;19(1):25-30. doi: 10.4183/aeb.2023.25. Epub 2023 Aug 14.
3
Distinct serum steroid profiles between adrenal Cushing syndrome and Cushing disease.肾上腺库欣综合征和库欣病的血清类固醇谱不同。
Front Endocrinol (Lausanne). 2023 May 16;14:1158573. doi: 10.3389/fendo.2023.1158573. eCollection 2023.
4
DHEAS for the prediction of subclinical Cushing's syndrome: perplexing or advantageous?脱氢表雄酮用于预测亚临床库欣综合征:令人困惑还是具有优势?
Endocrine. 2015 Mar;48(2):669-76. doi: 10.1007/s12020-014-0387-7. Epub 2014 Aug 22.
5
Mifepristone reduces insulin resistance in patient volunteers with adrenal incidentalomas that secrete low levels of cortisol: a pilot study.米非司酮降低分泌低水平皮质醇的肾上腺意外瘤患者志愿者的胰岛素抵抗:一项初步研究。
PLoS One. 2013;8(4):e60984. doi: 10.1371/journal.pone.0060984. Epub 2013 Apr 5.
6
Subclinical hypercortisolism: debatable or visible on the lightbox?亚临床皮质醇增多症:在阅片灯上是有争议还是显而易见?
Endocrine. 2012 Aug;42(1):7-8. doi: 10.1007/s12020-012-9689-9.
7
Hormonal activity in clinically silent adrenal incidentalomas.临床无症状肾上腺偶发瘤中的激素活性。
Arch Med Sci. 2012 Feb 29;8(1):97-103. doi: 10.5114/aoms.2012.27288.
8
Subclinical hypercortisolism and CT appearance in adrenal incidentalomas: a multicenter study from Southern Sweden.亚临床皮质醇增多症与肾上腺意外瘤的 CT 表现:来自瑞典南部的一项多中心研究。
Endocrine. 2012 Aug;42(1):164-73. doi: 10.1007/s12020-012-9622-2. Epub 2012 Feb 17.
9
Clinical and biochemical impact of BCL1 polymorphic genotype of the glucocorticoid receptor gene in patients with adrenal incidentalomas.糖皮质激素受体基因 BCL1 多态性基因型对肾上腺意外瘤患者的临床和生化影响。
J Endocrinol Invest. 2012 Apr;35(4):395-400. doi: 10.3275/7840. Epub 2011 Jul 5.
10
Endocrine incidentalomas--challenges imposed by incidentally discovered lesions.内分泌偶发瘤——偶然发现的病变带来的挑战。
Nat Rev Endocrinol. 2011 Jun 28;7(11):668-80. doi: 10.1038/nrendo.2011.92.